Izotropic Corporation
1R3.F
0.13 EUR
1 Tag: -0.77% (-0.00 EUR)
Der Alarm wird direkt gespeichert, ohne auf die Homepage zu springen.
Kursalarme fuer 1R3.F
Bitte anmelden, um Kursalarme zu sehen und zu speichern.
Finanzen
Unternehmensinfo
Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a breast CT imaging system. The company was incorporated in 2016 and is headquartered in Surrey, Canada.
Aktuelle News
-
Izotropic Executes Formal Agreement with Izotropic Africa for Exclusive Distribution Throughout Africa and the GCC
Vorschau anzeigen
Vancouver, British Columbia and Casablanca, Morocco--(Newsfile Corp. - July 2, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing IzoView, a dedicated breast CT imaging system for the more accurate screening and diagnosis of breast cancers, announces that, further to its April 29, 2026 announcement, it has executed the Formal Agreement (the "Formal Agreement") with Izotropic Africa ("IZAF"), together with..
-
Izotropic Africa Launches Operations in Casablanca
Vorschau anzeigen
Vancouver, British Columbia and Casablanca, Morocco--(Newsfile Corp. - April 29, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing IzoView, a dedicated breast CT imaging system for the more accurate screening and diagnosis of breast cancers, announces the official launch of Izotropic Africa in Casablanca, Morocco, and the appointment of Mr. Mohammed Sair as General Manager. Advancing Regional Operations...
-
Izotropic Announces Debt Settlement
Vorschau anzeigen
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - April 21, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces that it has entered into a debt settlement agreement (the "Agreement") with a lender (the "Lender") to settle a portion of the.
-
IZOZF Presents Opportunity for Investors
Vorschau anzeigen
By Brad Sorensen, CFA OTCQB: IZOZF | CSE: IZO READ THE FULL IZOZF RESEARCH REPORT With the investment world increasingly interested in smaller companies in search of value and growth, we want to highlight one of our favorite ideas for investors. Izotropic Corporation (OTCQB: IZOZF; CSE: IZO) is a medical technology company focused on transforming breast cancer detection through its proprietary
-
Izotropic's "Izotropic Africa" Enters Partnership Discussions with the Mohammed VI Foundation for Science & Health
Vorschau anzeigen
Vancouver, British Columbia, and Sacramento, California--(Newsfile Corp. - February 25, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces that, further to its February 18th announcement regarding the formation "Izotropic Africa" under a Letter Agreement, the...